Bendamustine is a antineoplastic alkylating agent, used in the treatment of chronic lymphocytic leukaemia and follicular lymphoma.
EML status history
First added in 2015 (TRS 994) for Chronic lymphocytic leukaemia or small lymphocytic lymphoma
Added in 2015 (TRS 994) for Follicular lymphoma
- Parenteral > General injections > unspecified: 45 mg per 0.5 mL; 180 mg per 2 mL